IN2014DN09383A - - Google Patents

Info

Publication number
IN2014DN09383A
IN2014DN09383A IN9383DEN2014A IN2014DN09383A IN 2014DN09383 A IN2014DN09383 A IN 2014DN09383A IN 9383DEN2014 A IN9383DEN2014 A IN 9383DEN2014A IN 2014DN09383 A IN2014DN09383 A IN 2014DN09383A
Authority
IN
India
Prior art keywords
grape seed
seed extract
anthocyanidins
inflammation
oxidative stress
Prior art date
Application number
Other languages
English (en)
Inventor
Chulani Kappagoda
Britt Burton-Freeman
Indika Edirisingue
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of IN2014DN09383A publication Critical patent/IN2014DN09383A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN9383DEN2014 2012-04-10 2013-04-10 IN2014DN09383A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261622339P 2012-04-10 2012-04-10
US13/841,673 US20140023737A1 (en) 2012-04-10 2013-03-15 Modulation of Oxidative Stress, Inflammation, and Impaired Insulin Sensitivity with Grape seed Extract
PCT/US2013/035944 WO2013155166A1 (en) 2012-04-10 2013-04-10 Modulation of oxidative stress, inflammation, and impaired insulin sensitivity with grape seed extract

Publications (1)

Publication Number Publication Date
IN2014DN09383A true IN2014DN09383A (ja) 2015-07-17

Family

ID=49328123

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9383DEN2014 IN2014DN09383A (ja) 2012-04-10 2013-04-10

Country Status (5)

Country Link
US (3) US20140023737A1 (ja)
EP (1) EP2836225A4 (ja)
CN (1) CN104379157A (ja)
IN (1) IN2014DN09383A (ja)
WO (1) WO2013155166A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3270707B1 (en) * 2015-03-16 2020-10-28 Nature's Sunshine Products Inc. Phytocomplexes exhibiting multiple, synergistic antioxidant activities
JP7296189B2 (ja) 2016-07-22 2023-06-22 株式会社エーゼット ブドウ種子抽出物を含む更年期障害改善剤
JP7279943B2 (ja) * 2020-07-03 2023-05-23 株式会社エーゼット ブドウ種子抽出物を含む更年期障害改善剤
FR3114497B1 (fr) * 2020-09-29 2023-06-02 Activinside Composition comprenant des monomères de flavanol et de l’ε-viniférine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544581B1 (en) * 1999-06-22 2003-04-08 Canandaigua Wine Company, Inc. Process for extraction, purification and enrichment of polyphenolic substances from whole grapes, grape seeds and grape pomace
PT1937091E (pt) * 2005-09-28 2015-09-01 Constellation Brands Inc Extrato de uva, suplemento alimentar do mesmo e processos para os mesmos
JP5230431B2 (ja) * 2005-09-28 2013-07-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 前高血圧の個体及び／又はメタボリックシンドロームの個体において血圧を降下させるための方法

Also Published As

Publication number Publication date
US20150258159A1 (en) 2015-09-17
EP2836225A4 (en) 2015-11-04
EP2836225A1 (en) 2015-02-18
WO2013155166A1 (en) 2013-10-17
US20140023737A1 (en) 2014-01-23
CN104379157A (zh) 2015-02-25
US20150258160A1 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
PH12015500407A1 (en) Methods of treating hypertriglyceridemia
EA201170669A1 (ru) Лечение пирфенидоном пациентов с атипичной функцией печени
MX2014004548A (es) Metodos para tratar pacientes pediatricos usando dexmedetomidina.
MX2012007806A (es) Composiciones farmaceuticas para administracion oral de peptidos de insulina.
WO2012023623A3 (ja) ハンター症候群の治療剤
NZ606964A (en) A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
MX2013000694A (es) Vitamina c y vitamina k libre de cromo, y composiciones de estas para tratar un estado o enfermedad en las que interviene nfkb.
UA105191C2 (ru) Лечение пирфенидоном пациентов с атипической функцией печени
WO2013028818A8 (en) Pyrimido- pyridazinone compounds and use thereof
BRPI1007732A2 (pt) aparelho para administração de medicamentos para a administração de um aerossol incluindo um medicamento para um paciente, kit para a administração de um aerossol incluindo um medicamento para um paciente e método de administração de um aerossol incluindo um medicamento para um paciente
IN2014DN09383A (ja)
WO2013155528A3 (en) Methods for reducing brain inflammation, increasing insulin sensitivity, and reducing ceramide levels
MX356317B (es) Tratamiento de síntomas asociados a gastroparesia femenina.
WO2013177067A3 (en) Herbal composition for treatment of gastrointestinal inflammatory diseases and method to prepare and use thereof
MX342417B (es) Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales.
MX2014014814A (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
GB201117490D0 (en) Anti-inflammatory compounds
MX2014014816A (es) Composicion farmaceutica para tratar inflamacion y dolor.
WO2013121300A3 (en) Methods for treating psoriasis and vascular inflammation
WO2012125871A3 (en) Aconitine compounds, compositions, uses, and preparation thereof
MY159675A (en) Clerodane derivatives for modulation of leukotriene receptor activity and related diseases
EA201201308A1 (ru) Противотуберкулезное лекарственное средство на основе 4-тиоуреидоиминометилпиридиния перхлората, способ его получения и способ лечения
RU2011108787A (ru) Способ лечения больных красным плоским лишаем слизистой полости рта
UA64823U (ru) Способ медицинской реабилитации больных синдромом хронической усталости
UA64820U (ru) Способ лечения больных с синдромом повышенной утомляемости на фоне хронической тонзиллярной инфекции